Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.

NCT05086939 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: Autologous MSCs
DRUG: Allogenic MSCs
DRUG: Hyaluronic Acid

Sponsor

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]